News

Several eye conditions are treated using anti-VEGF injections including retinal vein occlusion, diabetic macular edema and wet age-related macular degeneration.

This updated dosing schedule means that wet AMD and DME patients can now have their treatment plans tailored to their individual needs.

Study findings demonstrated a link between psoriasis and both dry and wet macular degeneration. 

Researchers have recently discovered that the enzyme, telomerase, plays a role in abnormal blood vessel formation in lab mice and this discovery may lead to new therapies in treating the wet form ...

EyePoint Pharmaceuticals announced the completion of the Phase 2 trial of their new experimental drug, vorolanib, for the treatment of wet age-related macular degeneration.

The current available therapies available to treat wet AMD involve intravitreal injections delivered every month to the back of the eye. 

A recent study reveals that one anti-VEGF treatment is more effective than another commonly used treatment.

Researchers believe the flavonoids in oranges offer protection against late stage macular degeneration.

Study results offer hope to patients with wet macular degeneration who are receiving anti-VEGF injections.